Diesel exhaust particles induce local IgE production in vivo and alter the pattern of IgE messenger RNA isoforms

D Diaz-Sanchez, A R Dotson, H Takenaka, A Saxon, D Diaz-Sanchez, A R Dotson, H Takenaka, A Saxon

Abstract

Diesel exhaust particles (DEP) have been implicated in the increased incidence of allergic airway disorders. We investigated the effects of DEP on localized immunoglobulin production by performing nasal challenges with varying doses of DEP and analyzing the local immune response in nasal lavages obtained before and after. A significant rise in nasal IgE but not IgG, IgA, IgM, or albumin was observed in subjects 4 d after challenge with 0.30 mg DEP, equivalent to exposure on an average Los Angeles day. Direct evidence for DEP-enhanced local production of IgE was that challenge increased the number of IgE-secreting cells in lavage fluid from < 1 in 2,000,000 to > 1 in 100,000 but did not alter the number of IgA-secreting cells. There was a concomitant increase in epsilon mRNA production in the lavage cells. Additionally, DEP altered the relative amounts of five different epsilon mRNAs generated by alternative splicing, mRNAs that code for different IgE proteins. These results show that DEP exposure in vivo causes both quantitative and qualitative changes in local IgE production. The implication is that natural exposure to DEP may result in increased expression of respiratory allergic disease.

References

    1. Ciba Found Symp. 1989;147:188-201; discussion 201-4
    1. Int Arch Allergy Appl Immunol. 1989;90(1):1-7
    1. Toxicology. 1990 Jan-Feb;60(1-2):15-25
    1. J Immunol Methods. 1990 Aug 28;132(1):37-43
    1. J Exp Med. 1990 Dec 1;172(6):1861-4
    1. J Immunol. 1991 Mar 1;146(5):1478-83
    1. J Immunol. 1991 Mar 1;146(5):1496-502
    1. J Immunol. 1991 Mar 15;146(6):1836-42
    1. Am Rev Respir Dis. 1991 Jun;143(6):1304-11
    1. J Immunol. 1992 Jan 1;148(1):129-36
    1. Immunology. 1992 Jan;75(1):196-201
    1. J Exp Med. 1992 Jul 1;176(1):233-43
    1. J Allergy Clin Immunol. 1992 Aug;90(2):224-9
    1. J Immunol. 1992 Aug 15;149(4):1470-5
    1. Eur J Immunol. 1993 Jan;23(1):159-67
    1. J Immunol. 1993 May 1;150(9):3671-80
    1. J Allergy Clin Immunol. 1993 Oct;92(4):616-23
    1. J Biol Chem. 1994 Jan 7;269(1):456-62
    1. Immunopharmacology. 1993 Sep-Oct;26(2):105-12
    1. Clin Allergy. 1988 May;18(3):295-304
    1. Am Rev Respir Dis. 1970 Sep;102(3):430-7
    1. Toxicol Appl Pharmacol. 1984 Jan;72(1):169-76
    1. J Immunol. 1984 Jun;132(6):2844-9
    1. J Allergy Clin Immunol. 1985 May;75(5):594-8
    1. J Allergy Clin Immunol. 1986 Apr;77(4):616-23
    1. J Allergy Clin Immunol. 1987 Apr;79(4):639-45
    1. Ann Allergy. 1987 Apr;58(4):265-70
    1. Biochem Biophys Res Commun. 1987 May 29;145(1):25-33
    1. J Allergy Clin Immunol. 1988 Oct;82(4):527-34
    1. FASEB J. 1988 Nov;2(14):3003-9
    1. Ciba Found Symp. 1989;147:205-22; discussion 222-9

Source: PubMed

3
Abonnieren